News – Page 955 – Endpoints News

Catching Catalyst Pharma by surprise, FDA approves Jacobus LEMS drug for pediatric patients — based on adult data

7 years ago

Watch out AbbVie and J&J, AstraZeneca just took another big swing at one of your star cancer drug franchises

7 years ago

Top MedImmune research exec joins the team now running Immunocore in wake of an R&D restructuring at AstraZeneca

7 years ago

One of the world's top experts in coronary heart disease is spearheading a new gene editing upstart out to transform ...

7 years ago

GW Pharma scores another PhIII win for its cannabinoid in rare form of epilepsy

7 years ago

Esperion shares surge as FDA waves off panel review; Adaptimmune buoyed by a positive data snapshot

7 years ago

The top 50 biotechs by market cap — and what their CEOs’ compensation deals tell us about biopharma

7 years ago

Bill Haney's Skyhawk spears another marquee alliance for its work drugging RNA in Takeda neuro pact

7 years ago

Pfizer enters Alnylam, Ionis' TTR turf with early approval for cardiomyopathy drug, carrying a $225K price tag

7 years ago

Hit by setbacks, Lundbeck's Deborah Dunsire inks a $400M cannabinoid buyout, adding a discovery site

7 years ago

New Zolgensma data suggest comparable efficacy to Spinraza — analysts

7 years ago

Cytokinetics' comeback attempt with second-gen muscle drug is slammed by a PhII failure in ALS

7 years ago

Pioneering mRNA CEO Stéphane Bancel bags an eye-popping $58M compensation deal in wake of record IPO

7 years ago

Vendu! Weeks after Sanofi cuts ties to Alnylam, the pharma giant offloads $842M of its stock

7 years ago

The (corrected) list of the world's top 20 pharma companies

7 years ago

Genkyotex picks out silver linings from failed PhII, braces for pivotal study in primary biliary cholangitis

7 years ago

FDA rejects Acacia's lead drug — again — due to the same manufacturing issue

7 years ago

FDA expands approval of Agios' Tibsovo; AstraZeneca's long-acting diabetes drug secures US nod

7 years ago

Microcap biotech VistaGen turned to pennystock after PhII results show its depression drug doesn't work solo

7 years ago

As backlash mounts in the wake of a disastrous PhIII flop, Eisai goes deeper with 2 new hires

7 years ago

Peer Review: Anil Singhal assumes leadership of Adicet Bio; Adaptive Biotech woos Genentech vet as CMO

7 years ago

Did a disaster crush your stock in 2018? These biotechs were happy to come up with some rich compensation deals for ...

7 years ago

Insys founder, former execs face decades in jail after being found guilty in landmark opioid case

7 years ago

Woodcock details upcoming changes to NDA and BLA review process

7 years ago

First page Previous page 952 953 954955956 957 958 Next page Last page